Science Daily - Heart Disease
MAY 5, 2025
People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a recent study of more than a million people. The protective effect of the vaccine lasts for up to eight years and is particularly pronounced for men, people under the age of 60 and those with unhealthy lifestyles.
Med Page Today
MAY 7, 2025
(MedPage Today) -- Obicetrapib provided dramatic reductions in LDL cholesterol, without noticeable side effects, in a phase III trial of high-risk individuals already on maximal lipid-lowering therapy. In adults with heterozygous familial hypercholesterolemia.
HCPLive
MAY 6, 2025
This analysis highlighted the cardiovascular safety of systemic psoriasis drugs using a prospective cohort trial design.
Cardiomatics
MAY 6, 2025
We are proud to announce our partnership with Arseus Medical , a leading distributor of medical technology in the Benelux region. This partnership brings innovation straight to cardiology clinics across the Netherlands and Belgium. What the Cardiomatics Arseus Medical Partnership Means Together with Arseus Medical, Cardiomatics is now part of a unified, end-to-end solution for cardiac diagnostics combining high-quality Holter recorders with AI-powered ECG interpretation in one integrated offeri
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Heart Sisters
MAY 4, 2025
"Out of the 700+ scientific papers presented at my first national cardiology conference, only four focused specifically on women's heart disease. FOUR!? Out of HUNDREDS!?" As you might guess, hearing that appalling news became the real story behind that conference for me.
Science Daily - Heart Disease
MAY 9, 2025
New research shows that the gum disease bacterium P. gingivalis can slip into the bloodstream and infiltrate the heart. There, it quietly drives scar tissue buildup -- distorting the heart's architecture, disrupting electrical signals, and raising the risk of atrial fibrillation.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
Med Page Today
MAY 4, 2025
(MedPage Today) -- "CA$H 4 SEALED & UNEXPIRED DIABETIC TEST STRIPS -- CALL NOW." This message, printed in black on a neon yellow poster board, hangs just outside the $1.1 billion Charlotte R. Bloomberg Children's Center at Johns Hopkins.
Journal of Cardiovascular Pharmacology
MAY 5, 2025
Artificial intelligence (AI) has emerged as a transformative tool in healthcare through data analysis, pattern recognition and predictive modeling capabilities. AI-driven approaches have the potential to positively transform patient care through personalized treatment regimens comprising antiplatelet and anticoagulant therapy. This review explores the integration of AI in guiding antithrombotic therapies, highlighting the potential to improve patient outcomes through personalized medicine.
Journal of Cardiovascular Electrophysiology
MAY 9, 2025
Dual-chamber leadless pacemakers were implanted successfully in 99.4% of patients, with a mean total procedure time of 64.3min, mean implant-to-implant communication success in >90% of beats, and a 30-day complication-free rate of 98.9%. ABSTRACT Introduction The AVEIR DR pacemaker (Abbott) is a dual-chamber leadless pacemaker (LP) system that includes right atrial and right ventricular helix-fixation LPs (ALP, VLP), with atrioventricular synchrony maintained via wireless communication betwee
HCPLive
MAY 8, 2025
Explore innovative strategies for asthma management that prioritize shared decision-making and address environmental, social, and behavioral factors.
Med Page Today
MAY 6, 2025
(MedPage Today) -- In a nationwide Korean study, live zoster vaccination was linked with lower risks of heart disease, including major adverse cardiovascular events, heart failure, ischemic heart disease, and other outcomes. (European Heart Journal.
American College of Cardiology
MAY 6, 2025
FAVOR III Europe (Functional Diagnostic Accuracy of Quantitative Flow Ratio in Online Assessment of Coronary Stenosis III Europe) was a multicenter, randomized, open-label, noninferiority trial to compare clinical outcomes of quantitative flow ratio (QFR)-guided and fractional flow reserve (FFR)-guided revascularization in patients with intermediate coronary stenosis (40-90% diameter stenosis by visual estimation) at 12 months.
CardiacWire
MAY 7, 2025
Results from NewAmsterdam Pharmas Phase 3 BROADWAY and TANDEM trials suggest that obicetrapib could be an effective LDL-C lowering treatment , both on its own or combined with another drug. TANDEM examined the effects of a fixed-dose obicetrapib/ezetimibe combination therapy and found An LDL-C reduction of ~50% at day 84 of treatment compared to placebo.
HCPLive
MAY 7, 2025
Blockmans discussed data supporting upadacitinibs new indication and why the approval is important for patients with giant cell arteritis.
Circulation
MAY 4, 2025
Circulation, Volume 151, Issue 18 , Page 1309-1311, May 6, 2025.
American College of Cardiology
MAY 8, 2025
The ACC has named Viet Le, DMSc, MPAS, PA-C, FACC, to lead its CardioSmart patient engagement program.
Open Heart
MAY 7, 2025
Aims Four-dimensional flow cardiovascular MRI (4D flow CMR) has emerged as a promising technique for assessing aortic stenosis (AS). This study aimed to evaluate the agreement between 4D flow CMR and transthoracic echocardiography (TTE) in estimating peak aortic valve (AV) velocities (V Peak ), grading AS severity and predicting AV intervention in a real-world setting.
HCPLive
MAY 3, 2025
Compared with non-users, the cannabis use cohort showed significantly greater risks of acute pancreatitis flare pancreatic cancer, and all-cause mortality.
Frontiers in Cardiovascular Medicine
MAY 6, 2025
BackgroundCoronary microvascular dysfunction (CMD) predicts poor prognosis in patients with coronary artery disease (CAD). However, the impact of intravascular lithotripsy (IVL) on CMD remains unclear, and no studies have directly compared IVL and rotational atherectomy (RA) in the context of CMD.ObjectiveThis study aimed to evaluate CMD, as indicated by angiographic microvascular resistance (AMR), in patients undergoing IVL- or RA-assisted PCI for heavily calcified coronary lesions.MethodsThis
American College of Cardiology
MAY 8, 2025
Members of ACC's Reproductive Health & Cardio-Obstetrics Member Section met virtually with representatives from 11 congressional offices on May 7 to push for stronger federal action on maternal health.
Nature Reviews - Cardiology
MAY 5, 2025
Nature Reviews Cardiology, Published online: 06 May 2025; doi:10.1038/s41569-025-01160-z The physiological phenomenon whereby heart rate varies in phase with breathing in vertebrates has been known as respiratory sinus arrhythmia. In this Expert Recommendation, the authors argue that this terminology is potentially misleading and propose replacing it with the term respiratory heart rate variability, which avoids pathological connotations.
HCPLive
MAY 8, 2025
Horst explains the importance of addressing depression and anxiety in patients with IBD and steps clinicians can take to support their patients mental health.
CardiacWire
MAY 7, 2025
Marea Therapeutics presented positive data from the Phase 2a clinical trial of its fat-targeting monoclonal antibody, MAR001, that could help address lipid and metabolic drivers of ASCVD. Originally developed by Novartis, MAR001 targets the ANGPTL4 protein in body fat tissue, which helps it lower remnant cholesterol and triglycerides in the blood. To assess MAR001s impact on remnant cholesterol and triglycerides, researchers randomized 55 patients with hypertriglyceridemia to one of three doses
American College of Cardiology
MAY 8, 2025
The use of optical coherence tomography (OCT) plus predefined algorithmic management achieved better stent implantation results than angiographic guidance when performing PCI in patients with calcified lesions.
Society of Thoracic Surgeons - Adult Cardiac
MAY 7, 2025
Webinar Latin Heart Rounds Series: Current Outcomes of the Norwood Operation gmckinney Wed, 05/07/2025 - 15:05 May 30, 2025 During this webinar, a panel of top surgeons and pediatric cardiologists will review current outcomes of the challenging Norwood operation, including cases found in the STS National Database. Topics will include: Patient selection Surgical primary palliation vs. hybrid approach with both surgical bands and more recent pulmonary flow restrictors Technical aspects of surgical
HCPLive
MAY 8, 2025
MAR001 significantly lowers remnant cholesterol and triglycerides in Phase 2a data, offering hope for high-risk cardiovascular patients.
Med Page Today
MAY 3, 2025
(MedPage Today) -- WASHINGTON -- The Neuroguard carotid stent system, with its integrated embolic filter, continued to show good results at 2 years for people with carotid artery stenosis deemed poor candidates for surgery, based on the PERFORMANCE.
American College of Cardiology
MAY 8, 2025
The ACC and Singapore Cardiac Society (SCS) are in Singapore for the ACC Asia 2025 Together With SCS 36th Annual Scientific Meeting, bringing together leading experts and cardiovascular clinicians from across Asia to examine emerging trends and evidence-based strategies in the prevention and management of patients with heart disease.
Medical Xpress - Cardiology
MAY 9, 2025
A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke.
HCPLive
MAY 8, 2025
Najy Issa, MD, describes underwhelming universal HBV screening uptake since 2023 CDC guidelines were implemented and steps to get more patients screened.
European Journal of Heart Failure
MAY 4, 2025
Vasodilators in acute heart failure: disconnection between beneficial pathophysiological and haemodynamic effects and clinical effects in randomized clinical trials. AHF, acute heart failure; ASCEND-AHF, A Study Testing the Effectiveness of Nesiritide in Patients With Acute Decompensated Heart Failure; BLAST-AHF, Biased Ligand of the Angiotensin receptor STudy in Acute Heart Failure; ED, emergency department; ELISABETH, Effect of an Emergency Department Care Bundle on 30-Day Hospital Discharge a
American College of Cardiology
MAY 6, 2025
Funded by the Congressionally Directed Medical Research Programs (CDMRP) of the Department of Defense, the WARRIOR (Women's IschemiA TRial to Reduce events In non-ObstRuctive CAD) Trial addresses the urgent need for evidence-based care in a growing population of patientsparticularly womenexperiencing ischemia without obstructive coronary artery disease (INOCA).
Medical Xpress - Cardiology
MAY 9, 2025
Tempted to skip the floss? Your heart might thank you if you don't. A new study from Hiroshima University (HU) finds that the gum disease bacterium Porphyromonas gingivalis (P. gingivalis) can slip into the bloodstream and infiltrate the heart. There, it quietly drives scar tissue buildupknown as fibrosisdistorting the heart's architecture, interfering with electrical signals, and raising the risk of atrial fibrillation (AFib).
HCPLive
MAY 7, 2025
These phase 3 findings from the ARRECTOR trial, published in JAMA, demonstrate rapid and significant relief from plaque psoriasis with roflumilast foam use.
Cardiometabolic Health Congress
MAY 6, 2025
Confronting the Silent Killer: Advancing Hypertension Awareness and Action May is High Blood Pressure Education Month Its time to elevate awareness around hypertensionthe silent killer affecting millions of Americansand in support, were offering a special incentive to attend this years annual Cardiometabolic Health Congress (CMHC) in Boston. This month is National High Blood Pressure Education Month the perfect opportunity for healthcare professionals to intensify efforts in combating hypertens
American College of Cardiology
MAY 7, 2025
The addition of aficamten to disopyramide was effective and well-tolerated in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) with persistent left ventricular overflow tract (LVOT) obstruction, and the withdrawal of disopyramide did not reduce the effectiveness of aficamten.
Expert insights. Personalized for you.
131 
Let's personalize your content